Eisai gives first glimpse into Alzheimer’s drug launch
Bio Pharma Dive
FEBRUARY 6, 2023
In the month since its U.S. approval, Leqembi has had its first sale, its first prescription written and its first administration to a patient
Mon.Feb 06, 2023
297 
Feinstein Institutes researchers discover new protein for sepsis treatment
Pharmaceutical Technology
FEBRUARY 6, 2023
Researchers at the Feinstein Institutes for Medical Research have discovered a new protein that can be a potential therapeutic target for lethal sepsis.
Join 15,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Astellas switches CEOs amid plans to pursue ‘aggressive’ growth
Bio Pharma Dive
FEBRUARY 6, 2023
Naoki Okamura, currently Astellas’ chief strategy officer, will replace current CEO Kenji Yasukawa as the company attempts to “further accelerate growth &rdquo
Pliant snags $287.5 million in oversubscribed public offering amid market uncertainty
Pharmaceutical Technology
FEBRUARY 6, 2023
In the midst of tough predictions for 2023 due to inflation and a difficult funding environment, Pliant Therapeutics closed an oversubscribed $287.5 million public offering to boost its rare disease pipeline.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
This webinar will go over the FDA's guidance on pharmacological and toxicological considerations for optimizing doses for prescription drugs.
Idorsia shares sink on ‘unexpected’ failure of drug study
Bio Pharma Dive
FEBRUARY 6, 2023
The Actelion spinout’s drug clazosentan, which is approved for use in Japan, didn’t significantly outperform a placebo in a Phase 3 study of patients with a particular type of stroke
Qurient partners with TB Alliance to develop telacebec
Pharmaceutical Technology
FEBRUARY 6, 2023
South Korean biotechnology company Qurient has entered a licence agreement with TB Alliance for the development and commercialisation of telacebec (Q203).
Sign up to get articles personalized to your interests!
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
More Trending
Alvotech and Advanz link-up for Xolair drive
Pharma Times
FEBRUARY 6, 2023
Alvotech will be responsible for supply and Advanz will oversee commercialisation of biosimilar
Pfizer’s 2023 pipeline: ‘We potentially will have the largest number of new product and indication launches that we’ve ever had in such a short period of time’
BioPharma Reporter
FEBRUARY 6, 2023
Pfizer currently has an unprecedented number of anticipated launches, says its CEO: with the company expecting to have 19 new products or indications in the market in the next 18 months. Markets & Regulations
PharmaTimes launches Clinical Researcher of the Year – the Americas 2023
Pharma Times
FEBRUARY 6, 2023
PharmaTimes announces the launch of the 2023 event and hopes to see returning contestants from previous years as well as some new faces
AstraZeneca automates DNA synthesis to slash costs and timelines
BioPharma Reporter
FEBRUARY 6, 2023
AstraZeneca has cut the cost and time needed to complete DNA synthesis by integrating an assembly framework into Benchling. Clinical Development
2022 Research: The Rapid Rise of Ocean Freight Visibility
Advertiser: FourKites
Download this a benchmark study from FourKites and The Journal of Commerce exploring how international shippers’ usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19.
Anatomy of a launch: As Leqembi takes first steps, Eisai maps Alzheimer's med's rollout
Fierce Pharma
FEBRUARY 6, 2023
Anatomy of a launch: As Leqembi takes first steps, Eisai maps Alzheimer's med's rollout fkansteiner Mon, 02/06/2023 - 10:06
Kidney Cancer UK makes NICE plea
Pharma Times
FEBRUARY 6, 2023
Charity highlights the need to find kidney cancer early and for better guidance among doctors
Led by Merck, Vertex and Lilly, pharma's share prices largely climbed in '22 despite economic angst
Fierce Pharma
FEBRUARY 6, 2023
Led by Merck, Vertex and Lilly, pharma's share prices largely climbed in '22 despite economic angst kdunleavy Tue, 02/07/2023 - 00:03
Jesduvroq (daprodustat) is FDA Approved for Anemia due to Chronic Kidney Disease
XTalks
FEBRUARY 6, 2023
GlaxoSmithKline LLC (GSK) recently announced that the US Food and Drug Administration (FDA) approved Jesduvroq (daprodustat), a new once-a-day oral treatment for anemia due to chronic kidney disease (CKD).
An Innovative & Creative Problem Solver Approach to Selling in the Medical Device Space
Speaker: Steve Goldstein, Sales Leader
Currently in sales or involved in a business that depends on strong sales results? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC. You will absorb critical strategies to become a trusted partner in greater sales success.
PharmaTimes launches Clinical Researcher of the Year – the Americas 2023
Pharma Times
FEBRUARY 6, 2023
PharmaTimes announces the launch of the 2023 event and hopes to see returning contestants from previous years as well as some new faces
Medical Device Coatings and Modification Technologies
Roots Analysis
FEBRUARY 6, 2023
Medical Device Coatings – From Supplementary Protection Constituents to Necessary Tools for Various Functions Over the past 50 years, the medical device industry has seen several notable developments.
Bionova Scientific Begins Plant Expansion Project
Pharmaceutical Commerce
FEBRUARY 6, 2023
CDMO is commissioning third GMP biologics facility in Fremont.
With Humira under pressure, AbbVie puts bigger M&A deals back on the table: WSJ
Fierce Pharma
FEBRUARY 6, 2023
With Humira under pressure, AbbVie puts bigger M&A deals back on the table: WSJ zbecker Mon, 02/06/2023 - 15:51
Mandatory COVID Vaccination Policy Template
Advertiser: Aggregage
The federal government is developing a rule requiring employers with more than 100 employees ensure their workers are vaccinated or produce a negative COVID test weekly before entering the workplace. So, what can your organization do to prepare? Get Paycor’s COVID Vaccination Policy Template to help communicate important details to your employees.
SARM1 Inhibitors: A Novel Approach Against Neurodegenerative Disorders
Roots Analysis
FEBRUARY 6, 2023
Presently, several industry and non-industry stakeholders are evaluating SARM1 inhibitors as potential therapeutic agents for the treatment of neurological disorders across various preclinical studies and early stages of clinical development, worldwide. Given the encouraging research outcomes, the players in this domain have received more than USD 10 million in grants, since 2014, from the various private and public organizations.
Informa Connect’s Access USA
Drug Channels
FEBRUARY 6, 2023
Informa Connect’s Access USA Hybrid Event | March 20-23, 2023, Philadelphia Marriott Downtown www.informaconnect.com/accessusa Exclusive Offer – Be sure to use your exclusive promo 23AUSA10 to save 10% off* of your registration We would like to introduce to you Access USA , industry’s resource for accelerating access, partnerships and collaboration to deliver superior patient outcomes. What is Access USA?
SCOPE 2023 - will decentralized trials be the hottest topic?
Outsourcing Pharma
FEBRUARY 6, 2023
One of the biggest questions being posed at this year's SCOPE summit, is whether the term 'decentralized clinical trials' will become redundant, as it forms the norm. Patient centricity
Astellas goes 'aggressive,' elevating chief strategy officer Okamura to replace CEO Yasukawa
Fierce Pharma
FEBRUARY 6, 2023
Astellas goes 'aggressive,' elevating chief strategy officer Okamura to replace CEO Yasukawa kdunleavy Mon, 02/06/2023 - 10:20
Hired and retired: New appointments in the biopharma industry
BioPharma Reporter
FEBRUARY 6, 2023
Catalent, SK bioscience and CureVac are among the companies welcoming new faces to top jobs. Biopharma Culture
Decentralized trials, SCOPE 2023's hottest topic?
Outsourcing Pharma
FEBRUARY 6, 2023
One of the biggest questions being posed at this year's SCOPE summit, is whether the term decentralized clinical trials will become redundant, as it forms the norm. Patient centricity
FDA to review Sandoz's BLA for biosimilar tackling osteoporosis in postmenopausal women
BioPharma Reporter
FEBRUARY 6, 2023
The Novartis subsidiary said its BLA submission to the US FDA is supported by a comprehensive analytical and clinical data package. Markets & Regulations
Aptar announces ‘highly recyclable’ nasal spray
Outsourcing Pharma
FEBRUARY 6, 2023
The company outlines that has designed a nasal spray pump that uses no metal parts to deliver OTC formulations. Drug Delivery
Bionova Scientific aims to quadruple GMP biologics manufacturing capacity
BioPharma Reporter
FEBRUARY 6, 2023
The project is the first phase of a wider strategic initiative to expand capacity and enhance end-to-end biologics development and manufacturing services at the US CDMO. Markets & Regulations
Which pharmaceutical drugs have the most drug patents in Hungary?
Drug Patent Watch
FEBRUARY 6, 2023
This chart shows the drugs with the most patents in Hungary. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.… The post Which pharmaceutical drugs have the most drug patents in Hungary?
Let's personalize your content